Decheng Capital Global Healthcare GP, LLC

CIK 1949027 · last filed 2025-10-15

Decheng Capital Global Healthcare GP, LLC is a corporate insider who has filed 5 SEC Form 4 insider transactions across 3 companies since 2024. The most recent filing shows the insider sold $1.8M of BYSI on Oct 15, 2025. Across all open-market trades the lifetime net is +$128.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $307.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$306.99M

Companies

3

Total Filings

5

Lifetime Open-Market Net

$128.92M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BYSI 10%+ Owner 1,617,409 $1.57 $2.54M -$9.08M 3 2025-10-15
AARD 10%+ Owner 2,333,887 $3.90 $9.10M $100.00M 1 2025-02-19
CGON 10%+ Owner 4,958,810 $59.56 $295.35M $38.00M 1 2024-04-09

Recent Filings

5 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-10-15 BYSI Sell (S) −1,076,712 -$1.81M EDGAR
2025-08-28 BYSI Sell (S) −24,654 -$44.1K EDGAR
2025-08-11 BYSI Sell (S) −2,366,616 -$7.22M EDGAR
2025-02-19 AARD Mixed +19,586,495 $100.00M EDGAR
2024-04-09 CGON Buy (P) +2,000,000 $38.00M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.